
Bupropion Hydrochloride
150 mg/1 · Extended-Release Tablet
By Slate Run Pharmaceuticals, LLC
- NDC
- 70436-059
- Route
- Oral
- Therapeutic class
- Aminoketone , Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-05)NDC 70436-059-05Available to order
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-01)NDC 70436-059-01Available to order
- 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-22)NDC 70436-059-22Available to order
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-02)NDC 70436-059-02Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

